Tuesday, February 19, 2013

Sanofi says FDA to review diabetes drug lixisenatide

Retweeted Medical News (@MedicalNews): Sanofi says FDA to review diabetes drug lixisenatide http://t.co/yd0UHyKF

via VAT ENGPlus Combo | VATPlus | MotionTrak http://t.co/yd0UHyKF

1 comment:

  1. impurities and metabolites, APIs for Veterinary, Natural Compounds, ADCs, Stem Cell Molecule and chiral compounds. Lixisenatide

    ReplyDelete